Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Concordance Medical, Edwards Lifesciences, Enterra Medical, Eosolutions, Jinghao Medical.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, RF Medical, Ventric Health.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astrazeneca, Biosyngen, Calliditas, Genexine, Life Molecular, Sumitomo.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Avistone.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Advanced Bifurcation Systmes, Life Molecular Imaging, Sintau Intl., Medinol, MTF Biologics, Think Surgical.
New and updated clinical data presented by biopharma firms, including: Akeso, Astrazeneca, Avistone, Daiichi, Dizal, Hummingbird, Immuneonicia, Immutep, Kazia, Transcenta.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beigene, Celltrion, Ipsen, Lipella, Pfizer, Regeneron, Rise, Sanofi, Spago, Sumitomo.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Insulet, Huizhou Jinghao, Ludica Medical, Medtronic, Vuno.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aspen Neuroscience, Pfizer Canada, SAB, Senhwa, Skyline, Spago, Sumitomo, Takeda, Vaxcyte.